(Reuters) -UK-based medical device company CMR Surgical has put itself up for sale at a valuation of up to $4 billion, the Financial Times reported on Tuesday, citing sources familiar with the matter.
The surgical robotics maker had hired advisers in recent weeks to initiate the sale process, likely to elicit interest from large strategic buyers, the report added.
Founded in 2014, CMR Surgical received U.S. Food and Drug Administration approval for the upgraded version of its flagship Versius surgical robot in October last year, to be used in gall bladder removal procedures.
Reuters could not immediately verify the report. CMR Surgical did not immediately respond to a request for comment outside regular business hours.
(Reporting by Ananya Palyekar in Bengaluru; Editing by Sonia Cheema)
Comments